查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1769929

外用药物市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Topical Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10个工作天内

价格

外用药物市场 - 报告范围

TMR 的全球外用药物市场报告研究了过去和当前的成长趋势及机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。该报告提供了 2019 年至 2035 年期间全球外用药物市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年全球外用药物市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括：分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解外用药物市场。

市场概况
2024 年的市场价值 1826.2亿美元
2035年的市场价值 3963亿美元
复合年增长率 7.2%

本报告深入探讨了全球外用药物市场的竞争格局。该报告确定了全球外用药物市场的主要参与者，并根据不同属性对每家公司进行了分析。本报告对全球外用药物市场参与者的属性进行了分析，包括公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020 年至 2035 年全球外用药物市场分析与预测

第五章：关键见解

  • 重要行业活动
  • PESTEL分析
  • 波特五力分析
  • 主要国家/地区报销情况
  • 管道分析
  • 市场未满足的需求
  • 政府倡议

第六章：全球市场分析与预测：依产品类型

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2020 年至 2035 年
    • 半固体製剂
      • 乳霜
      • 药膏和糊剂
      • 乳液
      • 凝胶
    • 液体配方
      • 暂停
      • 解决方案
    • 其他的
  • 市场吸引力分析：按产品类型

第七章：全球市场分析与预测：按应用

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按应用，2020 年至 2035 年
    • 皮肤病治疗
    • 伤口癒合
    • 抗发炎研究
    • 其他的
  • 市场吸引力分析：按应用

第八章：全球市场分析与预测：按配销通路

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020 年至 2035 年
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力分析：按配销通路

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020年至2035年
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第十章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第十二章：亚太市场分析与预测

第十三章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • Bayer AG
    • Cipla
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Bausch Health Companies Inc.
    • Hisamitsu Pharmaceuticals Co., Inc.
    • Merck KGaA
    • Glenmark Pharmaceuticals LTD.
    • MedPharm Ltd.
    • Galderma
    • Teva Pharmaceuticals
    • Boehringer Ingelheim International GmBH
    • Pfizer Inc.
Product Code: TMRGL86661

Topical Pharmaceuticals Market - Scope of Report

TMR's report on the global topical pharmaceuticals market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global topical pharmaceuticals market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global topical pharmaceuticals market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the topical pharmaceuticals market.

Market Snapshot
Market Value in 2024US$ 182.62 Bn
Market Value in 2035US$ 396.3 Bn
CAGR7.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global topical pharmaceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global topical pharmaceuticals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global topical pharmaceuticals market.

The report delves into the competitive landscape of the global topical pharmaceuticals market. Key players operating in the global topical pharmaceuticals market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global topical pharmaceuticals market profiled in this report.

Key Questions Answered in Global topical pharmaceuticals Market Report:

  • What is the sales/revenue generated by topical pharmaceuticals across all regions during the forecast period?
  • What are the opportunities in the global topical pharmaceuticals market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Topical Pharmaceuticals Market - Research Objectives and Research Approach

The comprehensive report on the global topical pharmaceuticals market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global topical pharmaceuticals market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global topical pharmaceuticals market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Pharmaceuticals Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Topical Pharmaceuticals Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. Reimbursement Scenario by Key Countries/Regions
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs of the Market
  • 5.7. Government Initiatives

6. Global Topical Pharmaceuticals Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Semi-Solid Formulations
      • 6.3.1.1. Creams
      • 6.3.1.2. Ointments & Pastes
      • 6.3.1.3. Lotions
      • 6.3.1.4. Gel
    • 6.3.2. Liquid Formulations
      • 6.3.2.1. Suspensions
      • 6.3.2.2. Solutions
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Topical Pharmaceuticals Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020 to 2035
    • 7.3.1. Dermatological Treatments
    • 7.3.2. Wound Healing
    • 7.3.3. Anti-inflammatory Studies
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Topical Pharmaceuticals Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Topical Pharmaceuticals Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Topical Pharmaceuticals Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 10.2.1. Semi-Solid Formulations
      • 10.2.1.1. Creams
      • 10.2.1.2. Ointments & Pastes
      • 10.2.1.3. Lotions
      • 10.2.1.4. Gel
    • 10.2.2. Liquid Formulations
      • 10.2.2.1. Suspensions
      • 10.2.2.2. Solutions
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Application, 2020 to 2035
    • 10.3.1. Dermatological Treatments
    • 10.3.2. Wound Healing
    • 10.3.3. Anti-inflammatory Studies
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Topical Pharmaceuticals Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Semi-Solid Formulations
      • 11.2.1.1. Creams
      • 11.2.1.2. Ointments & Pastes
      • 11.2.1.3. Lotions
      • 11.2.1.4. Gel
    • 11.2.2. Liquid Formulations
      • 11.2.2.1. Suspensions
      • 11.2.2.2. Solutions
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Application, 2020 to 2035
    • 11.3.1. Dermatological Treatments
    • 11.3.2. Wound Healing
    • 11.3.3. Anti-inflammatory Studies
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Topical Pharmaceuticals Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Semi-Solid Formulations
      • 12.2.1.1. Creams
      • 12.2.1.2. Ointments & Pastes
      • 12.2.1.3. Lotions
      • 12.2.1.4. Gel
    • 12.2.2. Liquid Formulations
      • 12.2.2.1. Suspensions
      • 12.2.2.2. Solutions
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Application, 2020 to 2035
    • 12.3.1. Dermatological Treatments
    • 12.3.2. Wound Healing
    • 12.3.3. Anti-inflammatory Studies
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Topical Pharmaceuticals Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Semi-Solid Formulations
      • 13.2.1.1. Creams
      • 13.2.1.2. Ointments & Pastes
      • 13.2.1.3. Lotions
      • 13.2.1.4. Gel
    • 13.2.2. Liquid Formulations
      • 13.2.2.1. Suspensions
      • 13.2.2.2. Solutions
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Application, 2020 to 2035
    • 13.3.1. Dermatological Treatments
    • 13.3.2. Wound Healing
    • 13.3.3. Anti-inflammatory Studies
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Topical Pharmaceuticals Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Semi-Solid Formulations
      • 14.2.1.1. Creams
      • 14.2.1.2. Ointments & Pastes
      • 14.2.1.3. Lotions
      • 14.2.1.4. Gel
    • 14.2.2. Liquid Formulations
      • 14.2.2.1. Suspensions
      • 14.2.2.2. Solutions
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Application, 2020 to 2035
    • 14.3.1. Dermatological Treatments
    • 14.3.2. Wound Healing
    • 14.3.3. Anti-inflammatory Studies
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Cipla
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. GSK plc
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Johnson & Johnson Services, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Novartis AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Bausch Health Companies Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Hisamitsu Pharmaceuticals Co., Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Merck KGaA
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Glenmark Pharmaceuticals LTD.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. MedPharm Ltd.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Galderma
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Teva Pharmaceuticals
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Boehringer Ingelheim International GmBH
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pfizer Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 03: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 04: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 06: Global Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 09: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 10: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 11: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 12: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 13: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 15: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 16: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 17: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 18: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 19: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 21: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 22: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 23: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 24: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 25: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 27: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 28: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 29: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
  • Table 31: Middle East & Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 33: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Semi-Solid Formulations, 2020 to 2035
  • Table 34: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Liquid Formulations, 2020 to 2035
  • Table 35: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 36: Middle East and Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

  • Figure 01: Global Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Semi-Solid Formulations, 2020 to 2035
  • Figure 04: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Liquid Formulations, 2020 to 2035
  • Figure 05: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 06: Global Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 07: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 08: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Dermatological Treatments, 2020 to 2035
  • Figure 09: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Wound Healing, 2020 to 2035
  • Figure 10: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Anti-inflammatory Studies, 2020 to 2035
  • Figure 11: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 12: Global Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 13: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 14: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035
  • Figure 15: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035
  • Figure 16: Global Topical Pharmaceuticals Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035
  • Figure 17: Global Topical Pharmaceuticals Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 18: Global Topical Pharmaceuticals Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 19: North America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 20: North America Topical Pharmaceuticals Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 21: North America Topical Pharmaceuticals Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 22: North America Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 23: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 24: North America Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 25: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 26: North America Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 27: North America Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 28: Europe Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: Europe Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 30: Europe Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 31: Europe Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 32: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 33: Europe Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 34: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 35: Europe Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 36: Europe Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 37: Asia Pacific Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 38: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 39: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 40: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 41: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 42: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 43: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 44: Asia Pacific Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 45: Asia Pacific Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 46: Latin America Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 47: Latin America Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 48: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 49: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 50: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 51: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 52: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 53: Latin America Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 54: Latin America Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
  • Figure 55: Middle East & Africa Topical Pharmaceuticals Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 56: Middle East & Africa Topical Pharmaceuticals Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 57: Middle East & Africa Topical Pharmaceuticals Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 58: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 59: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 60: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 61: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 62: Middle East and Africa Topical Pharmaceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 63: Middle East and Africa Topical Pharmaceuticals Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035